Cargando…
Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway
This study aimed to investigate the effect of sesamol (SEM) on the protein kinase A (PKA) pathway in obesity-related hepatic steatosis treatment by using high-fat diet (HFD)-induced obese mice and a palmitic acid (PA)-treated HepG2 cell line. SEM reduced the body weight gain of obese mice and allevi...
Autores principales: | Xu, Hai-Yan, Yu, Liang, Chen, Ji-Hua, Yang, Li-Na, Lin, Cui, Shi, Xiu-Quan, Qin, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071159/ https://www.ncbi.nlm.nih.gov/pubmed/31991934 http://dx.doi.org/10.3390/nu12020329 |
Ejemplares similares
-
Parathyroid hormone alleviates non-alcoholic liver steatosis via activating the hepatic cAMP/PKA/CREB pathway
por: Feng, Xu, et al.
Publicado: (2022) -
Sesamol promotes browning of white adipocytes to ameliorate obesity by inducing mitochondrial biogenesis and inhibition mitophagy via β3-AR/PKA signaling pathway
por: Lin, Cui, et al.
Publicado: (2021) -
Protective Effects of Sesamol against Liver Oxidative Stress and Inflammation in High-Fat Diet-Induced Hepatic Steatosis
por: Zheng, Wenya, et al.
Publicado: (2021) -
Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
por: Tong, Junlu, et al.
Publicado: (2022) -
Sesamol intervention ameliorates obesity-associated metabolic disorders by regulating hepatic lipid metabolism in high-fat diet-induced obese mice
por: Qin, Hong, et al.
Publicado: (2019)